233 event(s) found
Ninth JCA-AACR Special Joint Conference on Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers
The Japanese Cancer Association (JCA) and the AACR are proud to jointly present this Ninth JCA-AACR Special Joint Conference. This international collaboration will convene leading basic scientists and clinical researchers from around the world to share cutting-edge discoveries and emerging diagnostic and therapeutic opportunities in upper digestive and head and neck cancers. The conference will foster dynamic scientific exchange and collaboration, offering ample opportunities for meaningful discussions and interactions that are essential to advancing both basic research and clinical progress in the field. Sessions will also offer slots for proffered talks selected from highly rated abstract submissions.
ESMO Gastrointestinal Cancers Congress 2026
The ESMO Gastrointestinal Cancers Congress 2026 will take place from 1 to 4 July in Munich, Germany, as well as online, through a dedicated virtual platform. This key meeting will gather world-renowned specialists, clinical researchers, and medical professionals who are at the forefront of progress in the prevention, diagnosis, and treatment of gastrointestinal cancers. With an engaging scientific agenda that includes expert-led discussions, multidisciplinary tumour boards, debates on clinical controversies, and cutting-edge research presentations, participants will gain valuable insights into the evolving landscape of GI oncology. Topics will span the full continuum of care, from early detection and biomarker-driven therapies to innovations in systemic treatment and patient quality of life. Designed to foster knowledge exchange and collaboration, the congress offers numerous opportunities to connect with peers, discuss real-world challenges, and share perspectives on advancing GI cancer care. Be part of this influential gathering to drive change, shape clinical practice, and help improve outcomes for patients worldwide.
Pancreatic Cancer Conference 2026
This conference will bring together an international, multidisciplinary community to showcase the latest in scientific advances, ignite meaningful debate and enable new collaborations to catalyse progress in pancreatic cancer research. The programme will feature speakers from across the globe in scientific sessions and panel discussions, with talks spanning discovery, translational and clinical science. Themes range from examining the basic biology of the exposome and its role in tumour initiation and progression to unpicking the systemic physiological disruptions of late-stage disease. This is a must-attend event for anyone working in pancreatic cancer research or related disciplines and is open to researchers from all career stages from across the world. There will be poster sessions and extensive networking opportunities for early career researchers.
Tumour Microenvironment meeting and 3D Cancer Modelling workshop
Building on the success of four previous tumour microenvironment meetings, we will again showcase fantastic international tumour microenvironment research.
AACR Special Conference in Cancer Research: Breaking Barriers in the Fight Against Rare Cancers
Conference on breakthroughs and collaborative strategies targeting rare cancers.
Molecular Biology in Clinical Oncology Workshop
An intensive workshop providing a substantive overview of molecular biology, translational cancer research, current lab techniques, career development, and the best practices of grant writing for the aspiring physician-scientist.
Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine
The AACR Integrative Molecular Epidemiology Workshop is a transformative, week-long program designed to advance the skills of early-career researchers in molecular cancer epidemiology. With over 400 researchers trained since its inception, this workshop bridges the gaps between genetics, molecular markers, exposures, and advanced molecular methods. It fosters collaboration across disciplines such as epidemiology, bioinformatics, biostatistics, and molecular biology. Participants will gain hands-on experience in refining study designs, integrating omics technologies, geospatial data, and epidemiological methods to uncover insights into cancer etiology, prevention, and outcomes. The workshop emphasizes practical applications of cutting-edge tools while focusing on reproducibility, study feasibility, and quality control. Researchers will also engage in discussions on overcoming barriers to ensure that all benefit from advances in cancer research. Designed for emerging molecular epidemiologists, clinicians, statisticians, bioinformaticians, and researchers from allied fields, the workshop cultivates both technical expertise and a collaborative, forward-thinking mindset. Continuing to shape the future of cancer research, this workshop plays a key role in developing a diverse, skilled biomedical workforce. Join us to connect theoretical knowledge with real-world applications, advancing cancer research through team science and interdisciplinary collaboration.
2026 Pan Pacific Lymphoma Conference
The TAP Meetings listing includes hematologic oncology conferences focused on translational advances and clinical research in blood cancers, highlighting international collaboration and innovation.
AACR Drug Discovery and Development (AACR D3)
This groundbreaking global conference will redefine the future of oncology drug development by challenging conventional paradigms and catalyzing innovation across disciplines. Bringing together a diverse and influential community—including leaders from biotech, pharma, academia, regulatory agencies, technology, venture capital, and patient advocacy—this conference is being launched to spark bold ideas and foster transformative collaborations. Far beyond traditional didactic sessions, the conference will feature immersive and interactive formats to create dynamic networking opportunities and facilitate real-time problem-solving. Attendees will explore cutting-edge science, novel technologies, and emerging frameworks that promise to revolutionize how cancer therapies are discovered, developed, and delivered.
AACR/ASCO Methods in Clinical Cancer Research Workshop
The AACR/ASCO Methods in Clinical Cancer Research Workshop is an intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation, surgical oncology, and radiology.
IFHNOS 8th World Congress 2026
We are very excited to invite you to the 8th IFHNOS World Congress to be held in Brisbane, Australia, in August 2026, in collaboration with the Australian and New Zealand Head and Neck Cancer Society. The theme of the congress is “Global Harmonisation of Head and Neck Cancer Care”. IFHNOS is made up of over 70 member societies across 58 countries, and so this will truly be an engaging international head and neck cancer conference for the ages. Along with the organising team, we plan to deliver an exciting 4 days of a high quality scientific and social program. We hope to welcome you to Brisbane in August 2026!
ELRIG’s Scottish Forum: Translational medicine for womens health
More information coming soon…
ELRIG’s Irish Forum: Discovering Precision Medicines
More information coming soon…
SOHO 2026 Annual Meeting
The SOHO 2026 Annual Meeting is an international congress dedicated to advances in hematologic malignancies, featuring scientific sessions, clinical updates, and translational research in leukemia, lymphoma, and myeloma.
IASLC 2026 Hot Topic in Basic and Translational Science Meeting: Resistance to Immunotherapy
IASLC 2026 Hot Topic in Basic and Translational Science Meeting: Resistance to Immunotherapy organized by IASLC
2026 World Conference on Lung Cancer
2026 World Conference on Lung Cancer organized by IASLC
SIOP 2026
Coming soon...
SIOP 2026
Coming soon...
Symposium Cancer du Sein – 2e Edition
More information coming soon…
Congrès SCGP 2026 - 23e Journées de Chirurgie Gynécologique et Pelvienne
More information coming soon…
13th ACORD (Asia-Pacific Clinical Oncology Research Development) Workshop
This landmark workshop highlights ACORD’s ongoing commitment to advancing clinical cancer research across the Asia-Pacific. What began as a bold vision has evolved into a powerful transformative force—driving progress in oncology through education, collaboration, and innovation. Since its launch, ACORD has trained more than 550 early-career researchers through immersive workshops, building an exceptional network of cancer research leaders. In addition, over 600 researchers have participated in ACORD’s high-impact 1-day Clinical Research Concept Development programs since 2004. ACORD 2026 promises a dynamic week of expert mentorship, collaboration, and research excellence—empowering the next generation of oncology innovators.
13th ISCaM Annual Meeting: How nutrient availability impacts tumorigenesis
13th ISCaM Annual Meeting: How nutrient availability impacts tumorigenesis organized by ISCaM
World Cancer Congress 2026
World Cancer Congress 2026 will take place from 24-26 September 2026 in Hong Kong. It will be organised in collaboration with the Hong Kong Anti-Cancer Society, a long-standing UICC member organisation.
2ᵉ Colloque international sur l’implication du public et des patients dans la recherche sur le cancer - Quelles nouvelles tendances ?
S’inscrivant dans la continuité du « 1st International Workshop on Patient and Public Involvement (PPI) in Cancer Research » (Ebnõther, E., 2023), ce 2ᵉ Colloque international souhaite renforcer les liens entre partenaires francophones intéressés par la recherche en partenariat mais aussi sur le partenariat patient et offrir un espace de réflexion critique et constructif sur le sujet. Les objectifs de ce colloque sont : 1) clarifier ce que signifie "faire de la recherche en partenariat patient et avec le public" (Baillat et al., 2023) dans les différents domaines de recherche en oncologie tout en mettant en avant les innovations dans ce domaine ; 2) réaliser un état des travaux en cours sur le partenariat patient dans les soins, l’enseignement et la recherche en lien avec le cancer. Les chercheurs, patients partenaires engagés dans un projet de recherche, acteurs associatifs, soignants et acteurs institutionnels sont invités à soumettre leurs contributions pour explorer ces nouvelles tendances. Nous attendons des propositions venant de différentes approches disciplinaires et méthodologiques, et pouvant concerner tous les champs de la recherche sur le cancer. Les propositions à deux voix comprenant au moins un patient sont encouragées.